mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar

Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021

(2021) Summer E. Galloway et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

(2021) Merryn Voysey et al.   LANCET

Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study

(2021) Robert Challen et al.   BMJ-British Medical Journal

COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study

(2021) Victoria Jane Hall et al.   LANCET

Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants

(2021) Laith J. Abu-Raddad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic

(2021) Laith J. Abu-Raddad et al.   Scientific Reports

Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study

(2021) Jamie Lopez Bernal et al.   BMJ-British Medical Journal

Associations of Vaccination and of Prior Infection With Positive PCR Test Results for SARS-CoV-2 in Airline Passengers Arriving in Qatar

(2021) Roberto Bertollini et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses

(2021) Laith J Abu-Raddad et al.   JOURNAL OF TRAVEL MEDICINE

SARS-CoV-2 infection hospitalization, severity, criticality, and fatality rates in Qatar

(2021) Shaheen Seedat et al.   Scientific Reports

SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals

(2021) Peter V. Coyle et al.   iScience

Molecular and Serological Tests for COVID-19. A Comparative Review of SARS-CoV-2 Coronavirus Laboratory and Point-of-Care Diagnostics

(2020) Robert Kubina et al.   Diagnostics

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

(2020) Lindsey R. Baden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls

(2017) Jennifer R. Verani et al.   VACCINE

Analysis of matched case-control studies

(2016) Neil Pearce   BMJ-British Medical Journal

Analysis of matched case-control studies

(2016) Neil Pearce   BMJ-British Medical Journal

The test-negative design for estimating influenza vaccine effectiveness

(2013) Michael L. Jackson et al.   VACCINE

Is it necessary to adjust for calendar time in a test negative design?

(2013) Peter Jacoby et al.   VACCINE